|
|
 |
|
Viewing report
|
|
|
|
The 2011 US Cancer Diagnostics Market
Venture Planning Group, Oct 2010, Pages: 620
This report presents a comprehensive analysis of the US cancer diagnostics market, including:
Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals, commercial laboratories, physician offices and cancer clinics.Placements and installed base of automated and semiautomated analyzers used for cancer testing. Current instrumentation technologies and feature comparison of leading analyzers.Sales and market shares of leading suppliers.Emerging diagnostic technologies and their potential market applications.Product development opportunities.Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Business opportunities and strategic recommendations for suppliers. Contains 620 pages and 103 tables
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
The 2011 Spanish Cancer Diagnostics Market
Cancer Diagnostic Testing World Markets
The 2011 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
Drug Delivery in Cancer - Technologies, Markets and Companies
Molecular Diagnostics in Cancer Testing
Future Cancer Diagnostics Market: Growth Opportunities and Business Expansion Strategies
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Future Oncology
Cancer Bundle
Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report
|
|
|
|
